Current Oncology, Free Full-Text
By A Mystery Man Writer
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.
Pallimed: 07_05
How A.I. Is Being Used to Detect Cancer That Doctors Miss - The
Clinicopathological Characteristics and Prognosis of 91 Patients, smbot
Every year, the Naddeo/Aparicio - United Hospice, Inc.
Oncology News Today
Hematology/Oncology articles: The New England Journal of Medicine
New PubMed Updates: User Guide, MyNCBI, and more - NCBI Insights
Current Oncology, Free Full-Text, Skin Tone Construction Paper
Pathogenesis And Clinical Practice In Gastroenterology, 46% OFF
Current Oncology, Free Full-Text
Current Oncology 2023 - Browse Issues
Wiley Oncology & Hematology
Current Oncology, Free Full-Text, Skin Tone Construction Paper
